Mevlyq

eribulin mesylate · YES Pharmaceutical Development Services GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mevlyq, covering 2024-10-16 to 2024-10-16. Get the full timeline:

Most recent: EMA Authorised: Mevlyq (Eribulin mesylate) — YES Pharmaceutical Development Services GmbH